Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
Kiniksa Pharmaceuticals, Ltd. (KNSA)  
$19.53 0.66 (3.27%) as of 4:30 Fri 5/10


Download
   
Exchange: N/A
Security Type: Common
Shares Out: 35,410,000
Market Cap: 691.56(M)
Last Volume: 0 Avg Vol: 0
52 Week Range: $13.21 - $21.74
Level I Sector: N/A
Level II Sector: N/A
Level III Sector: N/A

Member Indexes:
   

Rankings:
     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  -
Guru Rank Value     :  -
Guru Occurances    :  -

 

            6 Months   1 Year   2 Year  
 
Company Profile   Kiniksa Pharmaceuticals is a biopharmaceutical company focused on discovering, acquiring, developing and commercializing therapeutic medicines for patients suffering from debilitating diseases with unmet medical need. Co.'s portfolio of assets include: ARCALYST® (rilonacept) is for the treatment of Cryopyrin-Associated Periodic Syndrome; mavrilimumab is targeting granulocyte-macrophage colony stimulating factor receptor alpha; vixarelimab is evaluating vixarelimab for the potential treatment of prurigo nodularis, a chronic inflammatory skin condition; and KPL-404 is a humanized monoclonal antibody that is designed to inhibit the CD40-CD154 interaction.

 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 0 0
Total Buy Value $0 $0 $0 $0
Total People Bought 0 0 0 0
Total Buy Transactions 0 0 0 0
Total Shares Sold 128,310 194,896 224,296 274,612
Total Sell Value $2,726,499 $3,969,036 $4,531,208 $5,316,305
Total People Sold 4 5 5 6
Total Sell Transactions 8 12 14 16
End Date 2024-02-11 2023-11-10 2023-05-12 2022-05-12

   
Records found: 241
  Page 2 of 10  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Megna Michael R CHIEF ACCOUNTING OFFICER   •       –      –    2024-04-01 4 D $19.70 $21,355 D/D (1,084) 19,062     -
   Megna Michael R CHIEF ACCOUNTING OFFICER   •       –      –    2024-04-01 4 OE $0.00 $0 D/D 2,558 20,146     -
   Patel Sanj K CHAIRMAN & CEO   •       •      –    2024-03-07 4 AS $21.02 $1,366,552 I/I (65,012) 0 -8%     
   Patel Sanj K CHAIRMAN & CEO   •       •      –    2024-03-06 4 AS $21.00 $117,222 I/I (5,582) 65,012 -7%     
   Patel Sanj K CHAIRMAN & CEO   •       •      –    2024-03-04 4 AS $21.31 $273,834 I/I (12,742) 70,594 -3%     
   Paolini John F. CHIEF MEDICAL OFFICER   •       –      –    2024-03-01 4 AS $21.77 $410,234 D/D (18,844) 44,892 -10%     
   Paolini John F. CHIEF MEDICAL OFFICER   •       –      –    2024-03-01 4 OE $1.86 $35,050 D/D 18,844 62,736     -
   Tessari Eben CHIEF OPERATING OFFICER   •       –      –    2024-03-01 4 AS $22.03 $26,194 D/D (1,189) 122,847 -10%     
   Tessari Eben CHIEF OPERATING OFFICER   •       –      –    2024-03-01 4 OE $1.59 $1,043 D/D 656 124,036     -
   Megna Michael R CHIEF ACCOUNTING OFFICER   •       –      –    2024-03-01 4 AS $21.45 $207,186 D/D (9,659) 17,588 -10%     
   Megna Michael R CHIEF ACCOUNTING OFFICER   •       –      –    2024-03-01 4 OE $8.83 $105,560 D/D 9,659 27,247     -
   Megna Michael R CHIEF ACCOUNTING OFFICER   •       –      –    2024-02-28 4 AS $21.79 $111,696 D/D (5,126) 17,588 -4%     
   Megna Michael R CHIEF ACCOUNTING OFFICER   •       –      –    2024-02-28 4 OE $8.83 $45,263 D/D 5,126 22,714     -
   Paolini John F. CHIEF MEDICAL OFFICER   •       –      –    2024-02-27 4 AS $21.03 $213,581 D/D (10,156) 44,892 -7%     
   Paolini John F. CHIEF MEDICAL OFFICER   •       –      –    2024-02-27 4 OE $1.86 $18,890 D/D 10,156 55,048     -
   Megna Michael R CHIEF ACCOUNTING OFFICER   •       –      –    2024-01-15 4 A $12.35 $7,200 D/D 583 17,588     -
   Ragosa Mark CHIEF FINANCIAL OFFICER   •       –      –    2024-01-03 4 AS $20.00 $240,000 D/D (12,000) 15,632 -2%     
   Ragosa Mark CHIEF FINANCIAL OFFICER   •       –      –    2024-01-03 4 OE $8.83 $105,960 D/D 12,000 27,632     -
   Megna Michael R CHIEF ACCOUNTING OFFICER   •       –      –    2024-01-02 4 AS $19.17 $319,564 D/D (16,670) 17,005 5%     
   Megna Michael R CHIEF ACCOUNTING OFFICER   •       –      –    2024-01-02 4 OE $13.88 $231,380 D/D 16,670 33,675     -
   Megna Michael R CHIEF ACCOUNTING OFFICER   •       –      –    2023-12-19 4 AS $19.13 $178,215 D/D (9,316) 17,005 2%     
   Megna Michael R CHIEF ACCOUNTING OFFICER   •       –      –    2023-12-19 4 OE $13.88 $129,306 D/D 9,316 26,321     -
   Paolini John F. CHIEF MEDICAL OFFICER   •       –      –    2023-12-07 4 AS $17.54 $504,758 D/D (28,600) 44,892 -5%     
   Paolini John F. CHIEF MEDICAL OFFICER   •       –      –    2023-12-07 4 OE $1.86 $53,196 D/D 28,600 73,492     -
   Levy Richard S   –       •      –    2023-11-03 4 OE $0.00 $0 D/D 2,777 7,777     -
  241 Records found
  1  2  3  4  5  6  7  8  9  Next   
  Page 2 of 10
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us